Ketamine plus Alcohol: What We Know and What We Can Expect about This

被引:6
|
作者
Correa Kobayashi, Natalia Harumi [1 ]
Farias, Sarah Viana [1 ]
Luz, Diandra Araujo [1 ]
Machado-Ferraro, Kissila Marvia [1 ]
da Conceicao, Brenda Costa [1 ]
Menezes da Silveira, Cinthia Cristina [1 ]
Pereira Fernandes, Luanna Melo [1 ]
Cartagenes, Sabrina de Carvalho [1 ]
Moraes Ferreira, Vania Maria [2 ]
Fontes-Junior, Eneas Andrade [1 ]
Ferraz Maia, Cristiane do Socorro [1 ]
机构
[1] Fed Univ Para, Fac Pharm, Inst Hlth Sci, Lab Pharmacol Inflammat & Behav, BR-66075110 Belem, Para, Brazil
[2] Univ Brasilia, Psychol Inst, Lab Psychobiol, Campus Univ Darcy Ribeiro Asa Norte, BR-70910900 Brasilia, DF, Brazil
关键词
ketamine; alcohol; drug abuse; addiction; toxicological effects; central nervous system; cardiorespiratory system; digestive system; renal system; CHRONIC ETHANOL EXPOSURE; NMDA RECEPTOR; URINARY-TRACT; NITRIC-OXIDE; K-HOLE; NEUROCOGNITIVE FUNCTION; PSYCHOTIC SYMPTOMS; RECREATIONAL USERS; DEPENDENT BLOCK; DRUG;
D O I
10.3390/ijms23147800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug abuse has become a public health concern. The misuse of ketamine, a psychedelic substance, has increased worldwide. In addition, the co-abuse with alcohol is frequently identified among misusers. Considering that ketamine and alcohol share several pharmacological targets, we hypothesize that the consumption of both psychoactive substances may synergically intensify the toxicological consequences, both under the effect of drugs available in body systems and during withdrawal. The aim of this review is to examine the toxicological mechanisms related to ketamine plus ethanol co-abuse, as well the consequences on cardiorespiratory, digestive, urinary, and central nervous systems. Furthermore, we provide a comprehensive discussion about the probable sites of shared molecular mechanisms that may elicit additional hazardous effects. Finally, we highlight the gaps of knowledge in this area, which deserves further research.
引用
收藏
页数:45
相关论文
共 50 条
  • [41] WHAT WE KNOW AND WHAT WE DONT KNOW ABOUT POLYELECTROLYTE GELS
    PRUDHOMME, RK
    YIN, YL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 264 - PMSE
  • [42] What We Know and What We Need to Know about Undergraduate Research
    Haeger, Heather
    Banks, John E.
    Smith, Camille
    Armstrong-Land, Monique
    SPUR-SCHOLARSHIP AND PRACTICE OF UNDERGRADUATE RESEARCH, 2020, 3 (04): : 62 - 69
  • [43] Memory, thinking, and aging - What we know about what we know
    Teri, L
    McCurry, SM
    Logsdon, RG
    WESTERN JOURNAL OF MEDICINE, 1997, 167 (04): : 269 - 275
  • [44] What We Know and What We Do Not Know about Dragon Trees?
    Madera, Petr
    Forrest, Alan
    Hanacek, Pavel
    Vahalik, Petr
    Gebauer, Roman
    Plichta, Roman
    Jupa, Radek
    Van Rensburg, Julian Jansen
    Morris, Miranda
    Nadezhdina, Nadezhda
    Vanickova, Lucie
    Jura-Morawiec, Joanna
    Wiland-Szymanska, Justyna
    Kalivodova, Hana
    Lengalova, Klara
    Rejzek, Martin
    Habrova, Hana
    FORESTS, 2020, 11 (02):
  • [45] TAVR in 2017-What we know? What to expect?
    Kourkoveli, Panagiota
    Spargias, Konstantinos
    Hahalis, George
    JOURNAL OF GERIATRIC CARDIOLOGY, 2018, 15 (01) : 55 - 60
  • [46] Outlying practice in MOHs surgery: What we know and what we can do about it
    Smith, H.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 9 - 9
  • [47] Nanofluidics: what is it and what can we expect from it?
    Eijkel, JCT
    van den Berg, A
    MICROFLUIDICS AND NANOFLUIDICS, 2005, 1 (03) : 249 - 267
  • [48] Quasicrystals. what do we know - what can we know?
    Steurer, Walter
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2017, 73 : C142 - C142
  • [49] What can we know?
    Welz, A.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2019, 33 (04): : 229 - 230
  • [50] Circulating tumor cell clusters: What we know and what we expect (Review)
    Hong, Yupeng
    Fang, Francia
    Zhang, Qi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (06) : 2206 - 2216